J. O. Jurado, I. B. Alvarez, V. Pasquinelli, G. J. Martínez, M. F. Quiroga, E. Abbate, R. M. Musella, H. E. Chuluyan and V. E. García, “Programmed Death (PD)-1: PD-Ligand 1/PD-Ligand 2 Pathway Inhibits T Cell Effector Functions during Human Tuberculosis,” Journal of Immunotherapy, Vol. 181, No. 1, 2008, pp. 116-125.

has been cited by the following article:

• TITLE: IFN-γ-, IL-4-, IL-17-, PD-1-Expressing T Cells and B Cells in Peripheral Blood from Tuberculosis Patients

  AUTHORS: Xiuyun He, Xiangyu Huang, Li Xiao, Juan Hao, Jing Li, Hongbing Chen, Yu Gao, Yazhen Zhao, Chuanzhi Zhu, Liqi Jiang

  KEYWORDS: Mycobacterium tuberculosis; B Cells; T Cells; Th Cells; PD-1

  JOURNAL NAME: Advances in Microbiology, Vol.2 No.4, December 25, 2012

  ABSTRACT: Although the efficacy of tuberculosis (TB) vaccines is tightly linked to cell-mediated immunity, some functions of T and B cells in TB patients remain unclear. To address how Mycobacterium tuberculosis infection inhibits T effector responses, we assessed the proportions of T cell subsets and B cells in peripheral blood from pulmonary TB (PTB) patients, pleural TB (PLTB) patients, and healthy subjects (HS, who showed purified protein derivative (PPD)-positive reactions) with flow cytometry. Compared to HS, PTB and PLTB patients exhibited higher proportions of B cells and Th17 cells, and lower proportions of Th2 cells and ratios of Th1 to Th17 cells and of Th2 to Th17 cells. PTB patients had higher CD4+ T cells and PD-1+ CD4+ T cells than HS. Newly diagnosed PTB patients (nPTB) had higher proportions of B cells than HS; in contrast, PTB patients subjected to effective treatments (oPTB) and HS shared similar proportions of B cells. oPTB patients had higher proportions of CD4+ T cells, Th17 cells, and PD-1+ CD4+ T cells than HS, but this difference did not occur in nPTB patients. These findings suggest that shifting ratios of Th1 to Th17 cells may be beneficial for M. tuberculosis to amplify.